Glacial® Skin by R2 Technologies, Inc. is a Silicon Valley-based company specializing in CryoAesthetic® medical devices. Founded in 2014 by Pansend Life Sciences and Blossom Innovations, the company focuses on developing and commercializing cutting-edge technologies for aesthetic providers and consumers. With licensed exclusive intellectual property from Massachusetts General Hospital and Blossom Innovations, R2 Technologies utilizes cold technology to modulate skin outcomes.
Having secured investment from its strategic partner, Huadong Medicine, and working in collaboration with scientific founders Dr. Rox Anderson, Dr. Dieter Manstein, and Dr. Henry Chan, R2 Technologies launched the Glacial® product portfolio in 2021. The company operates within the industries of Fashion, Health Care, Health and Wellness, Medical Devices, and Wellness Beauty.
There is no investment information
No recent news or press coverage available for Glacial® Skin by R2 Technologies, Inc..